gaba receptor β3 (PhosphoSolutions)
Structured Review

Gaba Receptor β3, supplied by PhosphoSolutions, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gaba receptor β3/product/PhosphoSolutions
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Inhibitory and excitatory synaptic neuroadaptations in the diazepam tolerant brain"
Article Title: Inhibitory and excitatory synaptic neuroadaptations in the diazepam tolerant brain
Journal: Neurobiology of disease
doi: 10.1016/j.nbd.2023.106248
Figure Legend Snippet: Synaptic and extrasynaptic GABA A receptor and gephyrin redistribution with seven-day DZP treatment in vivo. (A-F) Mice were treated i.p. once daily for seven days with Veh or DZP. Western blot analysis of collected cortical tissue was performed to assess protein levels of GABA A R subunits and gephyrin from total (A, B), synaptic (C, D), and extrasynaptic (E, F) fractions. Representative blots show five mice from each treatment group. Proteins quantified by western blot were normalized to GAPDH or KIR3.2 loading control. (B) Measurements of total protein levels revealed a significant increase in α1 ( p = 0.0018), β3 ( p = 0.0005), and γ2 ( p = 0.0002) subunits. The amount of synaptic α1 ( p = 0.0019), α4 ( p = 0.0028), and γ2 ( p = 0.0007) subunits also increased (D), while extrasynaptic α1 ( p = 0.0034) and α4 ( p = 0.0010) subunits were decreased and gephyrin ( p = 0.0040) was increased (F) (* p ≤ 0.05, ** p < 0.01, *** p < 0.001, Student’s t -test; n = 5–10 mice per treatment; error bars ± S.E.M.).
Techniques Used: In Vivo, Western Blot
Figure Legend Snippet: γ2 containing GABA A receptor composition is unchanged and tonic inhibition is reduced in DZP mice. (A) Immunoprecipitation of γ2-GABA A R from seven-day Veh- or DZP-treated mouse cortex was analyzed by DIA mass spectrometry to assess changes in receptor subunit composition ( n = 4 mice per treatment group). The intensity of α1–5 subunit-specific peptides are shown. Inset: Relative abundance (%) of α and β subunits associated with γ2 after seven-day DZP treatment. (B,C) (B) Left: representative traces with mIPSCs from seven-day DZP-treated animals before (dark red) and after (gray) 300 nM Ro 15–4513 application. Right: averaged mIPSCs before and after Ro 15–4513. (C) Quantification shows inverse agonist activity of Ro 15–4513, consistent with predominant receptors composed of γ2 with α1, α2, α3, α5-GABA A R subunits ( n = 5 cells; amplitude, p = 0.0191; frequency, p = 0.0179; tau, p = 0.0026). (D) GABA A R-mediated tonic current was measured in acute cortical slices from mice treated i.p. once daily for seven days with Veh or DZP. Picrotoxin-sensitive changes in holding current (V hold = −70 mV) were used to measure tonic inhibition in cortical slices from seven-day Veh- or DZP-treated mice. (E) Quantification revealed that GABA A R-mediated tonic current was significantly reduced (p = 0.0084) in DZP-treated mice ( n = 8) relative to Veh-treated mice ( n = 6). (E: ** p ≤ 0.01, Student’s t -test; C: * p ≤ 0.05, **p ≤ 0.01, paired t-test; error bars ± S.E.M.).
Techniques Used: Inhibition, Immunoprecipitation, Mass Spectrometry, Activity Assay
Figure Legend Snippet: Synaptic and extrasynaptic GABA A receptor and gephyrin redistribution with seven-day DZP treatment in vivo. (A-F) Mice were treated i.p. once daily for seven days with Veh or DZP. Western blot analysis of collected cortical tissue was performed to assess protein levels of GABA A R subunits and gephyrin from total (A, B), synaptic (C, D), and extrasynaptic (E, F) fractions. Representative blots show five mice from each treatment group. Proteins quantified by western blot were normalized to GAPDH or KIR3.2 loading control. (B) Measurements of total protein levels revealed a significant increase in α1 ( p = 0.0018), β3 ( p = 0.0005), and γ2 ( p = 0.0002) subunits. The amount of synaptic α1 ( p = 0.0019), α4 ( p = 0.0028), and γ2 ( p = 0.0007) subunits also increased (D), while extrasynaptic α1 ( p = 0.0034) and α4 ( p = 0.0010) subunits were decreased and gephyrin ( p = 0.0040) was increased (F) (* p ≤ 0.05, ** p < 0.01, *** p < 0.001, Student’s t -test; n = 5–10 mice per treatment; error bars ± S.E.M.).
Techniques Used: In Vivo, Western Blot
![Ablation of carotid body (CB) activity through carotid sinus nerve (CSN) resection heightens visceral white adipose tissue (WAT) metabolism in obese dysmetabolic rodents. (A) Panel shows a schematic illustration of the protocol used to evaluate mice WAT oxygen consumption rate (OCR). From (B) to (H) is described the effect of high fat (HF) diet and of CSN resection on the: (B) OCR per minute, reflecting adipose tissue metabolism, before and after stimulation with norepinephrine [15 μM] (left panel) or dopamine [100 nM] (right panel) in mice (3 pieces of tissue from 4–6 animals); (C) average basal OCR in mice (15–27 pieces of tissue from 4–6 animals) before the stimulation with norepinephrine and dopamine; (D) average OCR after stimulation with norepinephrine [15 μM] or dopamine [100 nM] (3 pieces of tissue from 4–6 animals); (E) Illustration of the molecular markers involved in brown adipocytes differentiation as well as the stimuli involved in the beiging of WAT; (F) average expression of PGC1α (92 kDa) ( n = 3–5); (G) average expression of PPARγ (53‐57 kDa) on visceral WAT of rats and mice ( n = 4–5)—representative western blots are shown on the top of the graphs; and (H) percentage of UCP1 protein labeled cells and percentage of mitotrackerTM Red CMXRos labeled cells (top panels) in the perienteric depot ( n = 4–5) in rats and mice; right panels show representative images of UCP1 and MitotrackerTM Red CMXRos labeled cells, Green—UCP1 labeled adipocytes; Red—MitotrackerTM Red CMXRos labeled adipocytes; Blue—DAPI labeled nuclei of the adipocytes; Yellow—Merge of UCP1 and MitotrackerTM Red CMXRos labeled cells. Gray and blue colors represent, respectively, normal chow (NC) and HF rats. Gray and red colors show NC and HF mice, respectively. Den—means animals submitted to CSN denervation/resection. Bars represent mean values ± SEM. Two‐Way ANOVA with Bonferroni multicomparison test. * p < 0.05, ** p < 0.01, *** p < 0.001 and **** p < 0.0001 comparing NC vs. HF groups, # p < 0.05, ## p < 0.01, ### p < 0.001 and ### p < 0.0001 comparing values with and without CSN resection.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_6215/pmc12186215/pmc12186215__APHA-241-e70074-g002.jpg)
